Senior Director, HR Business Partner providing strategic HR leadership in a biopharmaceutical company. Collaborating from a hybrid South San Francisco office to support Clinical Development and CMC teams.

BBOT (BridgeBio Oncology Therapeutics) is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies.
Initially formed as a subsidiary of BridgeBio, BBOT completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.
Browse and apply for open jobs at BBOT.
Senior Director, HR Business Partner providing strategic HR leadership in a biopharmaceutical company. Collaborating from a hybrid South San Francisco office to support Clinical Development and CMC teams.